最後更新日期:2020-04-20
最新消息
活動轉知【7/24-7/28 BIO Asia-Taiwan】國際重量級講者齊聚 把握接軌國際最佳機會!

【7/24-7/28 BIO Asia-Taiwan】國際重量級講者齊聚 把握接軌國際最佳機會!

 

亞洲最大的世界級生技展會-亞洲生技大會『BIO Asia-Taiwan 2019 』將於今年7月24-28日在台北舉行,由全球生技協會(BIO) 與台灣生物產業發展協會 (TBIO) 共同主辦,預估將有來自美、日、加、澳、瑞、德及東南亞等25國、1,500位生技產業及國際人士參與會議。

 

 

今年亞洲生技大會的主題為「Biotech as the Growth Engine for Asia」(投資生物科技,帶動亞太成長),5天的議程包含生技高峰論壇、生技大展、商機媒合、公司展望說明會、午餐會與晚宴等活動。在媒合方面,今年將全面採用BIO的全球媒合平台,效益及精彩可期。

 

展覽方面聯合各國及各州代表團、國際大藥廠及醫材公司、電子及資訊科技產業、醫療機構和醫學團體等共同參與,並特設各國展區、智慧醫療、全球製藥、精準醫療等展區。預計生技大展將擴大到1,700個攤位。

 

 

亞洲生技大會『BIO Asia-Taiwan 2019 』早鳥報名優惠中,歡迎各界共襄盛舉,踴躍報名:https://bioasiataiwan.com/zhtw/registration/plan

 

BIO Asia-Taiwan 國際重量級講者齊聚
第一波講者名單搶先公布

 

 

We are excited to announce that Jeff Karp of Harvard Medical School & MIT will join us for the Plenary Session. A brilliant researcher and compelling speaker, Jeff was recognized as one of the top innovators under the age of 35, received both the Young Investigator award from the Society for Biomaterials, and the Champion in Health Care Innovation. Jeff was a speaker at the TED Talk on Radical Simplicity, and the TED Talk on Bio. 

 

 

 

 

 

CONFIRMED SPEAKERS

 

 

  • Markus Bauss, Managing director, SHL group
  • You-Tzung Chen, Associate Professor, National Taiwan University
  • Judy Chou, SVP & Global Head of Biotech, Bayer
  • Samantha Du, Chairman and CEO, Zai Lab, China
  • James C. Greenwood, President and CEO, Biotechnology Innovation Organization (BIO)
  • Atsushi Hasuoka, APAC DAEWG
  • Robert Hofmeister, Chief Scientific Officer, TCR2 Therapeutics
  • Yoichiro Hamazaki, Deputy Senior General Manager, INFOCOM CORPORATION
  • Jeff Karp, Professor of Medicine, Harvard Medical School & MIT
  • Chien-Tsun Kuan, EVP/ COO & CTO, GenomeFrontier Therapeutics
  • Iduru Kokubu, Head of Healthcare Solutions Unit?? Fujitsu
  • Kazem Kazempour, President & CEO, Amarex Clinical Research
  • Heidi H. Kong, Investigator, Dermatology Branch/NIAMS, NIH
  • Rongjin Lin, Chairman, Center Laboratories Group
  • Chii-Wann Lin, Vice President, and General Director, Industrial Technology Research Institute
  • Fu-Tong, Liu, Vice Preside Director Division of Translational Research, Academia Sinica
  • Scott Liu, President, and CEO, Henlius Biotech
  • Timothy Lu, Associate Professor, MIT
  • Michael McManus, Professor, UC San Francisco
  • Kim Nearing, Managing Director, Cedrus Investments
  • Masayuki Nomura, International Affairs Committee, Forum for Innovative Regenerative Medicine (FIRM)
  • Chung-Kang Peng, Professor, Harvard University
  • Rajiv Rana, Head of Medical Affairs APAC, Merck
  • Josh Rose, Vice President, Global Head of Strategy, IQVIA
  • Talor Sax, CEO, eHealth Ventures
  • Yi Shi, Managing Director, Lilly Asia Ventures
  • Victor Shi, Chairman, BayHelix Group
  • Simranjit Singh, CEO Asia, Middle East & Africa, Guardant Healthcare
  • Jarret C.J. Su, Head of Healthcare, KPMG
  • Sam Thong, Managing Director, Morgan Stanley Hong Kong
  • Ethan Tu, Founder, Taiwan AI Labs
  • Jim Tsao, Chairman, and Head of China, Permira Private Equity Fund
  • Jonas Wang, Chairman & CEO, Stemcyte
  • Chun-Ying Wu, Director, Division of Translational Research, Taipei Veterans General Hospital
  • Yao Yi, CEO, BioCeltech
  • Alice Lin-Tsing Yu, Distinguished Chair Professor, Chang Gung University
  • Guo-Liang Yu, CEO, Apollomics

 

 

 

WHO IS SUPPORTING US

 

 

| PARTNERS |

 

 

 

BIO Asia-Taiwan 2019 Secretariat
register@taiwanbio.org.tw    |    www.bioasiataiwan.com    |   +886-2-7700-3883*13

 
 
 
 
辦公時間:AM 08:30-12:00 PM 13:00-18:00 E-mail: tpma.org@msa.hinet.net
地址:10675台北市敦化南路2段267號3樓 .電話:02-27365838 .傳真:02-27387689